|
Age : 68 Public asset : 82,333 USD Country of residence : Unknown Linked companies : Novavax, Inc. |
Biography of Gregory Glenn | |
|
Gregory M. Glenn founded Intercell USA, Inc. Dr. Glenn is President-Research & Development at Novavax, Inc.
He previously occupied the position of Chief Scientific Officer for Intercell AG, Chief Scientific Officer & Senior Vice President at Intercell USA, Inc., Research Scientist at Walter Reed Army Institute of Research and Associate-International Health at Johns Hopkins Bloomberg School of Public Health.
Dr. Glenn received an undergraduate degree from Whitman College and a doctorate from Oral Roberts University.
|
Current positions of Gregory Glenn | |
|
Name | Title |
Since |
Novavax, Inc. (Biotechnology & Medical Research) |
President-Research & Development |
2016 |
|
Holdings of Gregory Glenn | |
|
Name | Equities | % | Valuation |
Novavax, Inc. (NVAX) (Biotechnology & Medical Research) | 8,009 | 0.0094% | 82,333 USD |
|
Gregory Glenn : Personal Network | |
|
Name | Linked companies |
Gale Smith | Novavax, Inc. |
Sven Arne Andréasson | Novavax, Inc. |
Chris Dunne | Novavax, Inc. |
Russell Wilson | Novavax, Inc. |
Rachel K. King | Novavax, Inc. |
John Trizzino | Novavax, Inc. |
Richard Crowley | Novavax, Inc. |
Richard H. Douglas | Novavax, Inc. |
Silvia Taylor | Novavax, Inc. |
Brian Rosen | Novavax, Inc. |
|
© 2023 People and Ownership :
|
Gregory Glenn : Connections | |
|
|
Latest news about Gregory Glenn | |
|
2022 | Novavax Expects to Start Phase 2 Trial for Influenza-COVID-19 Combo Vaccine Candidate by 2022-end | MT |
2022 | Novavax Says COVID-19 Booster Dose Produces 'Robust' Antibodies Against Omicron Variants | MT |
2022 | Transcript : Novavax, Inc. Presents at Baird 2022 Global Healthcare Conference, Sep-13-2022 08:30 AM | CI |
2022 | Transcript : Novavax, Inc. Presents at H.C. Wainwright 24th Annual Global Investment Conference, Sep-12-2022 04:00 PM | CI |
2022 | Transcript : Novavax, Inc., Q2 2022 Earnings Call, Aug 08, 2022 | CI |
2022 | Transcript : Novavax, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 05:20 PM | CI |
2022 | Novavax Says Early COVID-Influenza Combo Vaccine Data 'Encouraging' | MT |
|
|